Long COVID Technology
As we approach the end of the year, we are also wrapping up a stellar, year-long webinar partnership with the Global Interdependence Center that has explored the pandemic’s long-term healthcare, […]
AIM ImmunoTech Announces Update on Ampligen Long Covid Development Program
Today, AIM ImmunoTech, an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders, and viral diseases, including COVID-19, provided an update […]
